NK and T cells in donors and recipients at day +100 after UBM or TCD transplantation
. | All . | UBM . | TCD . | P (UBM vs TCD) . |
---|---|---|---|---|
No. patients | 77 | 37 | 40 | |
CD56+/CD3- cells | ||||
Donor, % | 9.80 ± 0.71 | 10.71 ± 1.14 | 8.99 ± 0.86 | .23 |
Recipient, % | 40.16 ± 2.60 | 37.12 ± 3.57 | 42.98 ± 3.73 | .26 |
P, donor vs. recipient | < .001 | < .001 | < .001 | |
CD56-/CD3+ cells | ||||
Donor, % | 62.47 ± 1.28 | 61.08 ± 2.08 | 63.72 ± 1.55 | .31 |
Recipient, % | 28.61 ± 1.28 | 36.01 ± 3.62 | 21.76 ± 2.95 | .003 |
P, donor vs. recipient | < .001 | < .001 | < .001 | |
CD56+/CD3+ cells | ||||
Donor, % | 4.01 ± 0.42 | 4.16 ± 0.67 | 3.88 ± 0.52 | .74 |
Recipient, % | 3.20 ± 0.47 | 3.17 ± 0.61 | 3.22 ± 0.73 | .96 |
P, donor vs. recipient | .20 | .21 | .41 |
. | All . | UBM . | TCD . | P (UBM vs TCD) . |
---|---|---|---|---|
No. patients | 77 | 37 | 40 | |
CD56+/CD3- cells | ||||
Donor, % | 9.80 ± 0.71 | 10.71 ± 1.14 | 8.99 ± 0.86 | .23 |
Recipient, % | 40.16 ± 2.60 | 37.12 ± 3.57 | 42.98 ± 3.73 | .26 |
P, donor vs. recipient | < .001 | < .001 | < .001 | |
CD56-/CD3+ cells | ||||
Donor, % | 62.47 ± 1.28 | 61.08 ± 2.08 | 63.72 ± 1.55 | .31 |
Recipient, % | 28.61 ± 1.28 | 36.01 ± 3.62 | 21.76 ± 2.95 | .003 |
P, donor vs. recipient | < .001 | < .001 | < .001 | |
CD56+/CD3+ cells | ||||
Donor, % | 4.01 ± 0.42 | 4.16 ± 0.67 | 3.88 ± 0.52 | .74 |
Recipient, % | 3.20 ± 0.47 | 3.17 ± 0.61 | 3.22 ± 0.73 | .96 |
P, donor vs. recipient | .20 | .21 | .41 |
All percentage values are mean ± SEM.